Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Secukinumab intravenous placebo-controlled phase 2 study in uncontrolled asthma
2011-003117-41Phase 2Terminated
- Sponsor
- Novartis
- Start
- Sep 2011
- Modality
- Monoclonal Antibodies → Antibody-Based Therapeutics
- Countries
- 1
01
Overview
A Phase 2 trial of secukinumab in asthma, sponsored by Novartis. Started Sep 2011; status: terminated.
02
Drugs
secukinumab
03
Conditions
asthma
Beyond the preview
Go deeper on 2011-003117-41.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2011-003117-41.